"Das Comprehensive Cancer Center Zurich (CCCZ) ist ein gemeinsames Exzellenzzentrum des Universitätsspitals Zürich (USZ) und der Universität Zürich (UZH) unter Einbeziehung der Universitätsklinik Balgrist und des Universitäts-Kinderspitals Zürich. Am CCCZ werden innovative Krebsmedizin und Krebsforschung sowie die interdisziplinäre Aus- und Weiterbildung von Ärztinnen, Ärzten, Wissenschaftlerinnen, Wissenschaftlern und onkologisch tätigem Fachpersonal vereint."

During the past decade, University Hospital Zurich, Department of Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Zurich, Department of Oncology" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Zurich, Department of Oncology" are "Central Nervous System Tumors" (1 trials), "Cholangiocellular Carcinoma" (1 trials), "Lymphoma" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "University Hospital Zurich, Department of Oncology" in a lesser frequency.

Most popular intervention types in "University Hospital Zurich, Department of Oncology" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Chloroquine" (1 trials), "Gemcitabine" (1 trials), "Selective intra-arterial floxuridine and systemic gemcitabine and cisplatin" (1 trials) and "Temozolomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Zurich, Department of Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Zurich, Department of Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University Hospital Zurich, Department of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Zurich, Department of Oncology, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".